20
Participants
Start Date
February 28, 1998
Study Completion Date
January 31, 2006
Recombinant Tissue Plasminogen Activator
Heparin
Warfarin
National Institutes of Health Clinical Center (CC), Bethesda
National Institutes of Health Clinical Center (CC)
NIH